The Human Disharmony Loop (full) Including Inciting Factors. حسب James M. Friedman (22522150)

الموضوعات:

Baseline Severity of Disease by Scapular Dyskinesia Stage^1. حسب James M. Friedman (22522150)

الموضوعات:

The Human Disharmony Loop Clinical Presentation. حسب James M. Friedman (22522150)

الموضوعات:

Patient Demographics. حسب James M. Friedman (22522150)

الموضوعات:

Pain and Function Outcomes Following PM Tenotomy. حسب James M. Friedman (22522150)

الموضوعات:

Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

الموضوعات:

Normal Anatomy vs. Disharmonic Pathoanatomy. حسب James M. Friedman (22522150)

الموضوعات:

The Human Disharmony Loop (central). حسب James M. Friedman (22522150)

الموضوعات:

Sample Pain Diagrams. حسب James M. Friedman (22522150)

الموضوعات:

Patient Example. حسب James M. Friedman (22522150)

الموضوعات:

SEM images of improved soil under different freeze-thaw cycles. حسب Hongqi Wang (2208238)

الموضوعات:

The relationship between the thermal conductivity of the improved soil and the freeze-thaw cycle. حسب Hongqi Wang (2208238)

الموضوعات:

Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. حسب Jizhao Li (5856650)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. حسب Luqiong Liu (11537092)

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"